Tert-butyl N-[4-[3-bromo-1-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyridin-4-yl]oxy-3,5-difluorophenyl]carbamate
C25H22BrF2N3O5S — CID 142518430
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl N-[4-[3-bromo-1-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyridin-4-yl]oxy-3,5-difluorophenyl]carbamate
Tert-butyl N-[4-[3-bromo-1-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyridin-4-yl]oxy-3,5-difluorophenyl]carbamate (PubChem CID 142518430) has the molecular formula C25H22BrF2N3O5S and a molecular weight of 594.43 g/mol. Its IUPAC name is tert-butyl N-[4-[3-bromo-1-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyridin-4-yl]oxy-3,5-difluorophenyl]carbamate.
Molecular Properties
| Compound Name | Tert-butyl N-[4-[3-bromo-1-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyridin-4-yl]oxy-3,5-difluorophenyl]carbamate |
|---|---|
| PubChem CID | 142518430 |
| Molecular Formula | C25H22BrF2N3O5S |
| Molecular Weight | 594.43 g/mol |
| Exact Mass | 593.04 |
| IUPAC Name | tert-butyl N-[4-[3-bromo-1-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyridin-4-yl]oxy-3,5-difluorophenyl]carbamate |
| SMILES | Cc1ccc(S(=O)(=O)n2cc(Br)c3c(Oc4c(F)cc(NC(=O)OC(C)(C)C)cc4F)ccnc32)cc1 |
| InChI | InChI=1S/C25H22BrF2N3O5S/c1-14-5-7-16(8-6-14)37(33,34)31-13-17(26)21-20(9-10-29-23(21)31)35-22-18(27)11-15(12-19(22)28)30-24(32)36-25(2,3)4/h5-13H,1-4H3,(H,30,32) |
| InChIKey | JWXZBEDBFJDCMA-UHFFFAOYSA-N |
| XLogP | 6.76 |
| TPSA | 99.52 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 594.43 |
| LogP ≤ 5 | 6.76 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142518430 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.